Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer
- 1 July 1999
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 56 (1) , 25-34
- https://doi.org/10.1023/a:1006289811540
Abstract
The high potency and selectivity of new aromatase inhibitors has translated to greater efficacy and improved tolerability in comparison with established second‐line hormonal agents for advanced...Keywords
This publication has 24 references indexed in Scilit:
- Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancerBritish Journal of Cancer, 1996
- PP-8-1 Combined estroyen suppression and receptor (ER) blockade by buserelin (LHRH-A) and tamoxifen (TAM) in premenopausal metastatic breast cancer: Preliminary results of a 3-arm randomized study (EORTC 10881)European Journal Of Cancer, 1996
- A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerEuropean Journal Of Cancer, 1995
- 4-hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancerEuropean Journal Of Cancer, 1992
- The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patientsEuropean Journal Of Cancer, 1992
- Endocrinology and pharmacokinetics of oral 4-hydroxyandrostenedione in postmenopausal patients with advanced breast cancer [Poster 26]Steroids, 1987
- Aminoglutethimide in the treatment of advanced breast cancerCancer Treatment Reviews, 1984
- LOW-DOSE AMINOGLUTETHIMIDE IN TREATMENT OF ADVANCED BREAST CANCERThe Lancet, 1984
- A Standardised Multicentre Procedure for Plasma Gonadotrophin RadioimmunoassayAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1978